NATURE . COM {}

Matching Content Categories {📚}

• Science
• Education
• Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,554,915 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (10)

Reseller Advertisers (38)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$536,300 per month
Our estimates place Nature.com's monthly online earnings from display ads at $357,503 to $983,134.

Keywords {🔍}

cells, fig, ifnγ, cell, jak, resistance, resistant, hertcb, article, treated, tumor, btr, cancer, supplementary, min, google, scholar, data, levels, pbmcs, samples, signaling, lymphocytes, cas, car, parental, antibody, incubated, nature, treatment, killing, results, experiments, obtained, target, mice, cars, analysis, antibodies, tumors, ifngr, buffer, redirected, μgml, performed, expression, vivo, flow, analyzed, source,

Topics {✒️}

nature portfolio org/web/packages/pheatmap/index imaging ny-eso-1/lage-1-derived epitopes privacy policy cells promotes regional pmsgv1-her2-vl-vh-h8 advertising era-net transcan-2 initiative carlos alberto fajardo graft-versus-host disease nature 459 nature received research funds io/ reprints secondary antibody anti-biotin full development open enhancing n-glycan branching providing research facilities quantitative real-time pcr triple-negative breast cancer pan-hdac inhibitor trichostatin rnaseq libraries roche pharmaceutical research fixation/permeabilization working solution final library impaired ifn-γ signaling substrate ac-iepd-pna infinite m200 pro high lymphoma-directed cytotoxicity disrupting ifn-γ signaling unrestricted access early development catalytic p300/cbp inhibition anti-human ifn-γ tcr/mhc-antigen synapses thermo fisher scientific lenti-cas9-2a-blast antonio luque dimeric ifn-γ triggers assess t-cell activation irene rius ruiz macarena román alonso cells requires ifn-γ ifn-γ signaling pathway therapeutic cancer immunity tcr/mhc–antigen complex joaquín arribas horseradish peroxidase-conjugates antibodies

Questions {❓}

• JAK2 inhibitors for myeloproliferative neoplasms: what is next?
• Gov/bioproject/?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
         description:Immunotherapy has raised high expectations in the treatment of virtually every cancer. Many current efforts are focused on ensuring the efficient delivery of active cytotoxic cells to tumors. It is assumed that, once these active cytotoxic cells are correctly engaged to cancer cells, they will unfailingly eliminate the latter, provided that inhibitory factors are in check. T cell bispecific antibodies (TCBs) and chimeric antigen receptors (CARs) offer an opportunity to test this assumption. Using TCB and CARs directed against HER2, here we show that disruption of interferon-gamma signaling confers resistance to killing by active T lymphocytes. The kinase JAK2, which transduces the signal initiated by interferon-gamma, is a component repeatedly disrupted in several independently generated resistant models. Our results unveil a seemingly widespread strategy used by cancer cells to resist clearance by redirected lymphocytes. In addition, they open the possibility that long-term inhibition of interferon-gamma signaling may impair the elimination phase of immunoediting and, thus, promote tumor progression. Several mechanisms of resistance to T cell-engaging therapies have been described for solid tumors. Here, by using T cell bispecific antibodies and chimeric antigen receptors (CAR) T cells targeting HER2, the authors show that cancer cell intrinsic disruption of interferon-gamma signalling, including downregulation of JAK2, confers resistance to T-cell mediated cytotoxicity.
         datePublished:2021-02-23T00:00:00Z
         dateModified:2021-02-23T00:00:00Z
         pageStart:1
         pageEnd:13
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41467-021-21445-4
         keywords:
            Cancer immunotherapy
            Cancer therapeutic resistance
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_Fig6_HTML.png
         isPartOf:
            name:Nature Communications
            issn:
               2041-1723
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Enrique J. Arenas
               url:http://orcid.org/0000-0001-7076-2666
               affiliation:
                     name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                     address:
                        name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
                     name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
                     address:
                        name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alex Martínez-Sabadell
               url:http://orcid.org/0000-0002-9477-1396
               affiliation:
                     name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                     address:
                        name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Irene Rius Ruiz
               url:http://orcid.org/0000-0002-6097-7572
               affiliation:
                     name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                     address:
                        name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
                     name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
                     address:
                        name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Macarena Román Alonso
               url:http://orcid.org/0000-0001-8128-9528
               affiliation:
                     name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                     address:
                        name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marta Escorihuela
               affiliation:
                     name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                     address:
                        name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Antonio Luque
               affiliation:
                     name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                     address:
                        name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carlos Alberto Fajardo
               affiliation:
                     name:VHIO, Vall d’Hebron Barcelona Hospital Campus
                     address:
                        name:Tumor Immunology & Immunotherapy Group, VHIO, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alena Gros
               affiliation:
                     name:VHIO, Vall d’Hebron Barcelona Hospital Campus
                     address:
                        name:Tumor Immunology & Immunotherapy Group, VHIO, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christian Klein
               url:http://orcid.org/0000-0001-7594-7280
               affiliation:
                     name:Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development
                     address:
                        name:Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, Schlieren, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joaquín Arribas
               url:http://orcid.org/0000-0002-0504-0664
               affiliation:
                     name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                     address:
                        name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
                     name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
                     address:
                        name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
                        type:PostalAddress
                     type:Organization
                     name:Universitat Autónoma de Barcelona (UAB)
                     address:
                        name:Department of Biochemistry and Molecular Biology, Universitat Autónoma de Barcelona (UAB), Bellaterra, Spain
                        type:PostalAddress
                     type:Organization
                     name:Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute)
                     address:
                        name:Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
                        type:PostalAddress
                     type:Organization
                     name:Institució Catalana de Recerca i Estudis Avançats (ICREA)
                     address:
                        name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
      description:Immunotherapy has raised high expectations in the treatment of virtually every cancer. Many current efforts are focused on ensuring the efficient delivery of active cytotoxic cells to tumors. It is assumed that, once these active cytotoxic cells are correctly engaged to cancer cells, they will unfailingly eliminate the latter, provided that inhibitory factors are in check. T cell bispecific antibodies (TCBs) and chimeric antigen receptors (CARs) offer an opportunity to test this assumption. Using TCB and CARs directed against HER2, here we show that disruption of interferon-gamma signaling confers resistance to killing by active T lymphocytes. The kinase JAK2, which transduces the signal initiated by interferon-gamma, is a component repeatedly disrupted in several independently generated resistant models. Our results unveil a seemingly widespread strategy used by cancer cells to resist clearance by redirected lymphocytes. In addition, they open the possibility that long-term inhibition of interferon-gamma signaling may impair the elimination phase of immunoediting and, thus, promote tumor progression. Several mechanisms of resistance to T cell-engaging therapies have been described for solid tumors. Here, by using T cell bispecific antibodies and chimeric antigen receptors (CAR) T cells targeting HER2, the authors show that cancer cell intrinsic disruption of interferon-gamma signalling, including downregulation of JAK2, confers resistance to T-cell mediated cytotoxicity.
      datePublished:2021-02-23T00:00:00Z
      dateModified:2021-02-23T00:00:00Z
      pageStart:1
      pageEnd:13
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41467-021-21445-4
      keywords:
         Cancer immunotherapy
         Cancer therapeutic resistance
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_Fig6_HTML.png
      isPartOf:
         name:Nature Communications
         issn:
            2041-1723
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Enrique J. Arenas
            url:http://orcid.org/0000-0001-7076-2666
            affiliation:
                  name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                  address:
                     name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
                  name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
                  address:
                     name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alex Martínez-Sabadell
            url:http://orcid.org/0000-0002-9477-1396
            affiliation:
                  name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                  address:
                     name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Irene Rius Ruiz
            url:http://orcid.org/0000-0002-6097-7572
            affiliation:
                  name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                  address:
                     name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
                  name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
                  address:
                     name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Macarena Román Alonso
            url:http://orcid.org/0000-0001-8128-9528
            affiliation:
                  name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                  address:
                     name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marta Escorihuela
            affiliation:
                  name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                  address:
                     name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Antonio Luque
            affiliation:
                  name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                  address:
                     name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carlos Alberto Fajardo
            affiliation:
                  name:VHIO, Vall d’Hebron Barcelona Hospital Campus
                  address:
                     name:Tumor Immunology & Immunotherapy Group, VHIO, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alena Gros
            affiliation:
                  name:VHIO, Vall d’Hebron Barcelona Hospital Campus
                  address:
                     name:Tumor Immunology & Immunotherapy Group, VHIO, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christian Klein
            url:http://orcid.org/0000-0001-7594-7280
            affiliation:
                  name:Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development
                  address:
                     name:Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, Schlieren, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joaquín Arribas
            url:http://orcid.org/0000-0002-0504-0664
            affiliation:
                  name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
                  address:
                     name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
                  name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
                  address:
                     name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
                     type:PostalAddress
                  type:Organization
                  name:Universitat Autónoma de Barcelona (UAB)
                  address:
                     name:Department of Biochemistry and Molecular Biology, Universitat Autónoma de Barcelona (UAB), Bellaterra, Spain
                     type:PostalAddress
                  type:Organization
                  name:Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute)
                  address:
                     name:Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
                     type:PostalAddress
                  type:Organization
                  name:Institució Catalana de Recerca i Estudis Avançats (ICREA)
                  address:
                     name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Nature Communications
      issn:
         2041-1723
      volumeNumber:12
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
      address:
         name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
         type:PostalAddress
      name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
      address:
         name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
         type:PostalAddress
      name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
      address:
         name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
         type:PostalAddress
      name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
      address:
         name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
         type:PostalAddress
      name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
      address:
         name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
         type:PostalAddress
      name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
      address:
         name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
         type:PostalAddress
      name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
      address:
         name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
         type:PostalAddress
      name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
      address:
         name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
         type:PostalAddress
      name:VHIO, Vall d’Hebron Barcelona Hospital Campus
      address:
         name:Tumor Immunology & Immunotherapy Group, VHIO, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
         type:PostalAddress
      name:VHIO, Vall d’Hebron Barcelona Hospital Campus
      address:
         name:Tumor Immunology & Immunotherapy Group, VHIO, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
         type:PostalAddress
      name:Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development
      address:
         name:Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, Schlieren, Switzerland
         type:PostalAddress
      name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
      address:
         name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
         type:PostalAddress
      name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
      address:
         name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
         type:PostalAddress
      name:Universitat Autónoma de Barcelona (UAB)
      address:
         name:Department of Biochemistry and Molecular Biology, Universitat Autónoma de Barcelona (UAB), Bellaterra, Spain
         type:PostalAddress
      name:Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute)
      address:
         name:Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
         type:PostalAddress
      name:Institució Catalana de Recerca i Estudis Avançats (ICREA)
      address:
         name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Enrique J. Arenas
      url:http://orcid.org/0000-0001-7076-2666
      affiliation:
            name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
            address:
               name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
               type:PostalAddress
            type:Organization
            name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
            address:
               name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
               type:PostalAddress
            type:Organization
      name:Alex Martínez-Sabadell
      url:http://orcid.org/0000-0002-9477-1396
      affiliation:
            name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
            address:
               name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:Irene Rius Ruiz
      url:http://orcid.org/0000-0002-6097-7572
      affiliation:
            name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
            address:
               name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
               type:PostalAddress
            type:Organization
            name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
            address:
               name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
               type:PostalAddress
            type:Organization
      name:Macarena Román Alonso
      url:http://orcid.org/0000-0001-8128-9528
      affiliation:
            name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
            address:
               name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:Marta Escorihuela
      affiliation:
            name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
            address:
               name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:Antonio Luque
      affiliation:
            name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
            address:
               name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:Carlos Alberto Fajardo
      affiliation:
            name:VHIO, Vall d’Hebron Barcelona Hospital Campus
            address:
               name:Tumor Immunology & Immunotherapy Group, VHIO, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:Alena Gros
      affiliation:
            name:VHIO, Vall d’Hebron Barcelona Hospital Campus
            address:
               name:Tumor Immunology & Immunotherapy Group, VHIO, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:Christian Klein
      url:http://orcid.org/0000-0001-7594-7280
      affiliation:
            name:Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development
            address:
               name:Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, Schlieren, Switzerland
               type:PostalAddress
            type:Organization
      name:Joaquín Arribas
      url:http://orcid.org/0000-0002-0504-0664
      affiliation:
            name:Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus
            address:
               name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
               type:PostalAddress
            type:Organization
            name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
            address:
               name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
               type:PostalAddress
            type:Organization
            name:Universitat Autónoma de Barcelona (UAB)
            address:
               name:Department of Biochemistry and Molecular Biology, Universitat Autónoma de Barcelona (UAB), Bellaterra, Spain
               type:PostalAddress
            type:Organization
            name:Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute)
            address:
               name:Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
               type:PostalAddress
            type:Organization
            name:Institució Catalana de Recerca i Estudis Avançats (ICREA)
            address:
               name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
      name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
      name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
      name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
      name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
      name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
      name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
      name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
      name:Tumor Immunology & Immunotherapy Group, VHIO, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
      name:Tumor Immunology & Immunotherapy Group, VHIO, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
      name:Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, Schlieren, Switzerland
      name:Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
      name:Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
      name:Department of Biochemistry and Molecular Biology, Universitat Autónoma de Barcelona (UAB), Bellaterra, Spain
      name:Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
      name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

Social Networks {👍}(2)

• https://www.facebook.com/NatureCommunications
• https://twitter.com/NatureComms

External Links {🔗}(124)

• What's the financial outcome of https://orcid.org/0000-0001-7076-2666?
• Income figures for https://orcid.org/0000-0002-9477-1396
• How much revenue does https://orcid.org/0000-0002-6097-7572 bring in?
• How much does https://orcid.org/0000-0001-8128-9528 bring in each month?
• Monthly income for https://orcid.org/0000-0001-7594-7280
• Learn how profitable https://orcid.org/0000-0002-0504-0664 is on a monthly basis
• How much does https://gemtools.github.io/ pull in?
• What's the monthly income of https://cran.rproject.org/web/packages/pheatmap/index.html?
• What is the earnings of https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA674313?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=T%20cell-engaging%20therapies%E2%80%94BiTEs%20and%20beyond&journal=Nat.%20Rev.%20Clin.%20Oncol.&volume=16&pages=2825-434&publication_year=2020&author=Goebeler%2CM-E&author=Bargou%2CRC
• What is the earnings of https://doi.org/10.1016%2FS1470-2045%2819%2930823-X?
• How much does http://scholar.google.com/scholar_lookup?&title=CAR%20T%20cells%3A%20continuation%20in%20a%20revolution%20of%20immunotherapy&journal=Lancet%20Oncol.&doi=10.1016%2FS1470-2045%2819%2930823-X&volume=21&pages=e168-e178&publication_year=2020&author=Singh%2CAK&author=McGuirk%2CJP earn?
• How much money does https://doi.org/10.1016%2Fj.copbio.2019.11.020 make?
• How much does http://scholar.google.com/scholar_lookup?&title=Bispecific%20antibodies%20in%20cancer%20immunotherapy&journal=Curr.%20Opin.%20Biotechnol.&doi=10.1016%2Fj.copbio.2019.11.020&volume=65&pages=9-16&publication_year=2019&author=Rader%2CC generate monthly?
• Learn how profitable https://doi.org/10.3390%2Fantib8030041 is on a monthly basis
• How profitable is http://scholar.google.com/scholar_lookup?&title=Bispecific%20T-cell%20redirection%20versus%20chimeric%20antigen%20receptor%20%28CAR%29-T%20cells%20as%20approaches%20to%20kill%20cancer%20cells&journal=Antibodies&doi=10.3390%2Fantib8030041&volume=8&pages=41-68&publication_year=2019&author=Strohl%2C&author=Naso.%2C?
• Financial intake of https://doi.org/10.1038%2Fs41573-019-0028-1
• Income figures for http://scholar.google.com/scholar_lookup?&title=Bispecific%20antibodies%3A%20a%20mechanistic%20review%20of%20the%20pipeline&journal=Nat.%20Rev.%20Drug%20Discov.&doi=10.1038%2Fs41573-019-0028-1&volume=18&pages=585-608&publication_year=2019&author=Labrijn%2CAF&author=Janmaat%2CML&author=Reichert%2CJM&author=Parren%2CPWHI
• Profit of https://doi.org/10.1126%2Fscitranslmed.aaw2127
• How much does http://scholar.google.com/scholar_lookup?&title=T%20cell%20translation%20forward&journal=Sci.%20Transl.%20Med.&doi=10.1126%2Fscitranslmed.aaw2127&volume=11&publication_year=2019&author=Schultz%2CL&author=Mackall%2CC&author=Driving%2CCAR bring in each month?
• What's the revenue for https://doi.org/10.1146%2Fannurev-med-062617-035821?
• How much does http://scholar.google.com/scholar_lookup?&title=Redirected%20T%20cell%20cytotoxicity%20in%20cancer%20therapy&journal=Annu.%20Rev.%20Med.&doi=10.1146%2Fannurev-med-062617-035821&volume=70&pages=437-450&publication_year=2019&author=Clynes%2CRA&author=Desjarlais%2CJR bring in each month?
• How profitable is https://doi.org/10.1158%2F2159-8290.CD-18-0297?
• What's http://scholar.google.com/scholar_lookup?&title=CARs%20versus%20BiTEs%3A%20a%20comparison%20between%20T%20cell-redirection%20strategies%20for%20cancer%20treatment&journal=Cancer%20Discov.&doi=10.1158%2F2159-8290.CD-18-0297&volume=8&pages=924-934&publication_year=2018&author=Slaney%2CCY&author=Wang%2CP&author=Darcy%2CPK&author=Kershaw%2CMH's gross income?
• How much does https://doi.org/10.1056%2FNEJMra1706169 pull in?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Chimeric%20antigen%20receptor%20therapy&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJMra1706169&volume=379&pages=64-73&publication_year=2018&author=June%2CCH&author=Sadelain%2CM?
• How much revenue does https://doi.org/10.1016%2Fj.blre.2018.02.004 produce monthly?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Bispecific%20antibody%20based%20therapeutics%3A%20strengths%20and%20challenges&journal=Blood%20Rev.&doi=10.1016%2Fj.blre.2018.02.004&volume=32&pages=339-347&publication_year=2018&author=Thakur%2CA&author=Huang%2CM&author=Lum%2CLG is on a monthly basis
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30837712
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20resistance%20to%20CAR%20T%20cell%20therapy&journal=Nat.%20Rev.%20Clin.%20Oncol.&volume=16&pages=372-385&publication_year=2019&author=Shah%2CNN&author=Fry%2CTJ?
• https://doi.org/10.1056%2FNEJMoa1609783's financial summary
• How much profit does http://scholar.google.com/scholar_lookup?&title=Blinatumomab%20versus%20chemotherapy%20for%20advanced%20acute%20lymphoblastic%20leukemia&journal=N.%20Engl.%20J.%20Med&doi=10.1056%2FNEJMoa1609783&volume=376&pages=836-847&publication_year=2017&author=Kantarjian%2CH generate?
• Learn how profitable https://doi.org/10.1016%2FS1470-2045%2818%2930864-7 is on a monthly basis
• How much does http://scholar.google.com/scholar_lookup?&title=Long-term%20safety%20and%20activity%20of%20axicabtagene%20ciloleucel%20in%20refractory%20large%20B-cell%20lymphoma%20%28ZUMA-1%29%3A%20a%20single-arm%2C%20multicentre%2C%20phase%201-2%20trial&journal=Lancet%20Oncol.&doi=10.1016%2FS1470-2045%2818%2930864-7&volume=20&pages=31-42&publication_year=2019&author=Locke%2CFL net monthly?
• How much profit does https://doi.org/10.1158%2F1078-0432.CCR-18-2743 make?
• How much does http://scholar.google.com/scholar_lookup?&title=FDA%20approval%20summary%3A%20axicabtagene%20ciloleucel%20for%20relapsed%20or%20refractory%20large%20B-cell%20lymphoma&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-18-2743&volume=25&pages=1702-1708&publication_year=2019&author=Bouchkouj%2CN bring in each month?
• How much does https://doi.org/10.1038%2Fs41571-019-0297-y make?
• Profit of http://scholar.google.com/scholar_lookup?&title=Engineering%20strategies%20to%20overcome%20the%20current%20roadblocks%20in%20CAR%20T%20cell%20therapy&journal=Nat.%20Rev.%20Clin.%20Oncol.&doi=10.1038%2Fs41571-019-0297-y&volume=17&pages=147-167&publication_year=2020&author=Rafiq%2CS&author=Hackett%2CCS&author=Brentjens%2CRJ
• How much profit does https://doi.org/10.1016%2Fj.ccr.2014.02.025 generate?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=ERBB%20receptors%3A%20from%20oncogene%20discovery%20to%20basic%20science%20to%20mechanism-based%20cancer%20therapeutics&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2014.02.025&volume=25&pages=282-303&publication_year=2014&author=Arteaga%2CCL&author=Engelman%2CJA
• How much money does https://doi.org/10.1016%2FS1535-6108%2802%2900212-X make?
• How much money does http://scholar.google.com/scholar_lookup?&title=Conditional%20activation%20of%20Neu%20in%20the%20mammary%20epithelium%20of%20transgenic%20mice%20results%20in%20reversible%20pulmonary%20metastasis&journal=Cancer%20Cell&doi=10.1016%2FS1535-6108%2802%2900212-X&volume=2&pages=11-11&publication_year=2002&author=Moody%2CSE make?
• How much revenue does https://doi.org/10.1126%2Fscitranslmed.aat1445 generate?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=p95HER2-T%20cell%20bispecific%20antibody%20for%20breast%20cancer%20treatment&journal=Sci.%20Transl.%20Med.&doi=10.1126%2Fscitranslmed.aat1445&volume=10&publication_year=2018&author=Rius%20Ruiz%2CI?
• How much profit is https://doi.org/10.1016%2Fj.ccr.2005.10.012 making per month?
• How much does http://scholar.google.com/scholar_lookup?&title=TGF-beta%20directly%20targets%20cytotoxic%20T%20cell%20functions%20during%20tumor%20evasion%20of%20immune%20surveillance&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2005.10.012&volume=8&pages=369-380&publication_year=2005&author=Thomas%2CDA&author=Massagu%C3%A9%2CJ make?
• How much money does https://doi.org/10.1016%2Fj.immuni.2018.01.006 make?
• How much does http://scholar.google.com/scholar_lookup?&title=Interleukin-10%20directly%20inhibits%20CD8%2B%20T%20cell%20function%20by%20enhancing%20N-glycan%20branching%20to%20decrease%20antigen%20sensitivity&journal=Immunity&doi=10.1016%2Fj.immuni.2018.01.006&volume=48&pages=299-312&publication_year=2018&author=Smith%2CLK bring in each month?
• Financial intake of https://doi.org/10.1084%2Fjem.20050930
• How much profit does http://scholar.google.com/scholar_lookup?&title=B7-H4%20expression%20identifies%20a%20novel%20suppressive%20macrophage%20population%20in%20human%20ovarian%20carcinoma&journal=J.%20Exp.%20Med.&doi=10.1084%2Fjem.20050930&volume=203&pages=871-881&publication_year=2006&author=Kryczek%2CI make?
• How much does https://doi.org/10.1101%2Fcshperspect.a028480 pull in?
• How much money does http://scholar.google.com/scholar_lookup?&title=Interferon%20%CE%B3%20and%20its%20important%20roles%20in%20promoting%20and%20inhibiting%20spontaneous%20and%20therapeutic%20cancer%20immunity&journal=Cold%20Spring%20Harb.%20Perspect.%20Biol.&doi=10.1101%2Fcshperspect.a028480&volume=11&publication_year=2019&author=Alspach%2CE&author=Lussier%2CDM&author=Schreiber%2CRD make?
• How much does https://doi.org/10.1073%2Fpnas.95.26.15623 bring in each month?
• Learn how profitable http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=1998PNAS...9515623D is on a monthly basis
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Identification%20of%20genes%20differentially%20regulated%20by%20interferon%20alpha%2C%20beta%2C%20or%20gamma%20using%20oligonucleotide%20arrays&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.95.26.15623&volume=95&pages=15623-15628&publication_year=1998&author=Der%2CSD&author=Zhou%2CA&author=Williams%2CBR&author=Silverman%2CRH is on a monthly basis
• Discover the revenue of https://doi.org/10.1038%2Fnature07829
• What's the revenue for http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2009Natur.459..108H?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Histone%20modifications%20at%20human%20enhancers%20reflect%20global%20cell-type-specific%20gene%20expression&journal=Nature&doi=10.1038%2Fnature07829&volume=459&pages=108-112&publication_year=2009&author=Heintzman%2CND?
• Monthly income for https://doi.org/10.1158%2F2159-8290.CD-19-0813
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Impaired%20death%20receptor%20signaling%20in%20leukemia%20causes%20antigen-independent%20resistance%20by%20inducing%20CAR%20T-cell%20dysfunction&journal=Cancer%20Discov.&doi=10.1158%2F2159-8290.CD-19-0813&volume=10&pages=552-567&publication_year=2020&author=Singh%2CN?
• What's https://doi.org/10.1182%2Fblood.V95.6.2098's gross income?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=A%20recombinant%20bispecific%20single-chain%20antibody%2C%20CD19%20x%20CD3%2C%20induces%20rapid%20and%20high%20lymphoma-directed%20cytotoxicity%20by%20unstimulated%20T%20lymphocytes&journal=Blood&doi=10.1182%2Fblood.V95.6.2098&volume=95&pages=2098-2103&publication_year=2000&author=L%C3%B6ffler%2CA?
• What is the earnings of https://doi.org/10.3390%2Fijms20061283?
• How much money does http://scholar.google.com/scholar_lookup?&title=Killing%20mechanisms%20of%20chimeric%20antigen%20receptor%20%28CAR%29%20T%20cells&journal=Int.%20J.%20Mol.%20Sci.&doi=10.3390%2Fijms20061283&volume=20&publication_year=2019&author=Benmebarek%2CM-R make?
• Get to know what's the income of https://doi.org/10.1016%2Fj.molimm.2005.03.007
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Induction%20of%20regular%20cytolytic%20T%20cell%20synapses%20by%20bispecific%20single-chain%20antibody%20constructs%20on%20MHC%20class%20I-negative%20tumor%20cells&journal=Mol.%20Immunol.&doi=10.1016%2Fj.molimm.2005.03.007&volume=43&pages=763-771&publication_year=2006&author=Offner%2CS&author=Hofmeister%2CR&author=Romaniuk%2CA&author=Kufer%2CP&author=Baeuerle%2CPA each month?
• How much does https://doi.org/10.1038%2Fni1058 rake in every month?
• Profit of http://scholar.google.com/scholar_lookup?&title=T%20cell%20killing%20does%20not%20require%20the%20formation%20of%20a%20stable%20mature%20immunological%20synapse&journal=Nat.%20Immunol.&doi=10.1038%2Fni1058&volume=5&pages=524-530&publication_year=2004&author=Purbhoo%2CMA&author=Irvine%2CDJ&author=Huppa%2CJB&author=Davis%2CMM
• How much money does https://doi.org/10.1016%2Fj.ccr.2013.04.004 generate?
• http://scholar.google.com/scholar_lookup?&title=It%E2%80%99s%20the%20peptide-MHC%20affinity%2C%20stupid&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2013.04.004&volume=23&pages=429-431&publication_year=2013&author=Kammertoens%2CT&author=Blankenstein%2CT income
• How much profit does https://doi.org/10.4049%2Fjimmunol.176.12.7308 generate?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Quantifying%20and%20imaging%20NY-ESO-1%2FLAGE-1-derived%20epitopes%20on%20tumor%20cells%20using%20high%20affinity%20T%20cell%20receptors&journal=J.%20Immunol.&doi=10.4049%2Fjimmunol.176.12.7308&volume=176&pages=7308-7316&publication_year=2006&author=Purbhoo%2CMA?
• Find out how much https://doi.org/10.1073%2Fpnas.89.12.5321 earns monthly
• Income figures for http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=1992PNAS...89.5321K
• How much does http://scholar.google.com/scholar_lookup?&title=ERBB2%20amplification%20in%20breast%20cancer%20analyzed%20by%20fluorescence%20in%20situ%20hybridization&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.89.12.5321&volume=89&pages=5321-5325&publication_year=1992&author=Kallioniemi%2COP earn?
• Monthly income for https://doi.org/10.1073%2Fpnas.1716266115
• How much does http://scholar.google.com/scholar_lookup?&title=Chimeric%20antigen%20receptor%20T%20cells%20form%20nonclassical%20and%20potent%20immune%20synapses%20driving%20rapid%20cytotoxicity&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.1716266115&volume=115&pages=E2068-E2076&publication_year=2018&author=Davenport%2CAJ earn?
• How much money does https://doi.org/10.1182%2Fblood-2017-04-742288 make?
• How much profit is http://scholar.google.com/scholar_lookup?&title=JAK2%20inhibitors%20for%20myeloproliferative%20neoplasms%3A%20what%20is%20next%3F&journal=Blood&doi=10.1182%2Fblood-2017-04-742288&volume=130&pages=115-125&publication_year=2017&author=Bose%2CP&author=Verstovsek%2CS making per month?
• How much does https://doi.org/10.1016%2Fj.cell.2017.11.010 gross monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=A%20living%20biobank%20of%20breast%20cancer%20organoids%20captures%20disease%20heterogeneity&journal=Cell&doi=10.1016%2Fj.cell.2017.11.010&volume=172&pages=373-382&publication_year=2018&author=Sachs%2CN pull in monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Is%20an%20essential%20mediator%20in%20CD8%2B%20T%20Cell%20Killing%20of%20Theileria%20parva-infected%20cells&journal=Infect.%20Immun.&volume=87&publication_year=2019&author=Yang%2CJ&author=Pemberton%2CA&author=Morrison%2CWI&author=Connelley%2CT&author=Granzyme%2CB bring in each month?
• Income figures for https://link.springer.com/doi/10.1186/s13059-014-0550-8
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Moderated%20estimation%20of%20fold%20change%20and%20dispersion%20for%20RNA-seq%20data%20with%20DESeq2&journal=Genome%20Biol.&doi=10.1186%2Fs13059-014-0550-8&volume=15&publication_year=2014&author=Love%2CMI&author=Huber%2CW&author=Anders%2CS
• How much does https://doi.org/10.1101/060012 bring in each month?
• What's the financial outcome of https://doi.org/10.1016%2Fj.cels.2015.12.004?
• How much does http://scholar.google.com/scholar_lookup?&title=The%20molecular%20signatures%20database%20hallmark%20gene%20set%20collection&journal=Cell%20Syst.&doi=10.1016%2Fj.cels.2015.12.004&volume=1&pages=417-425&publication_year=2015&author=Liberzon%2CA earn?
• What's the total monthly financial gain of https://citation-needed.springer.com/v2/references/10.1038/s41467-021-21445-4?format=refman&flavour=references?
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Enrique%20J.%20Arenas
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Enrique%20J.%20Arenas%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alex%20Mart%C3%ADnez-Sabadell income
• What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alex%20Mart%C3%ADnez-Sabadell%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Irene%20Rius%20Ruiz
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Irene%20Rius%20Ruiz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Macarena%20Rom%C3%A1n%20Alonso
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Macarena%20Rom%C3%A1n%20Alonso%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Marta%20Escorihuela net monthly?
• Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Marta%20Escorihuela%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Antonio%20Luque earning monthly?
• What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Antonio%20Luque%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Carlos%20Alberto%20Fajardo
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Carlos%20Alberto%20Fajardo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alena%20Gros
• How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alena%20Gros%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christian%20Klein makes per month
• What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christian%20Klein%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Joaqu%C3%ADn%20Arribas?
• See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Joaqu%C3%ADn%20Arribas%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
• What's the monthly income of https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_MOESM1_ESM.pdf?
• How much does https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_MOESM2_ESM.pdf net monthly?
• How much cash flow does https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-021-21445-4/MediaObjects/41467_2021_21445_MOESM3_ESM.pdf have monthly?
• How much revenue does http://creativecommons.org/licenses/by/4.0/ bring in?
• Financial intake of https://s100.copyright.com/AppDispatchServlet?title=Acquired%20cancer%20cell%20resistance%20to%20T%20cell%20bispecific%20antibodies%20and%20CAR%20T%20targeting%20HER2%20through%20JAK2%20down-modulation&author=Enrique%20J.%20Arenas%20et%20al&contentID=10.1038%2Fs41467-021-21445-4©right=The%20Author%28s%29&publication=2041-1723&publicationDate=2021-02-23&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY
• https://crossmark.crossref.org/dialog/?doi=10.1038/s41467-021-21445-4 income
• What are the earnings of https://citation-needed.springer.com/v2/references/10.1038/s41467-021-21445-4?format=refman&flavour=citation?
• How much does https://doi.org/10.1186/s12943-024-02150-4 generate monthly?
• How much profit does https://doi.org/10.1007/s12032-024-02504-4 generate?
• What's the profit of https://doi.org/10.1038/s41467-024-53265-7?
• How much revenue does https://doi.org/10.1038/s43018-023-00570-7 bring in?
• Revenue of https://doi.org/10.1186/s13148-022-01316-5
• What is the monthly revenue of https://www.protocols.io/?
• What's the income of https://www.natureindex.com/?
• How much money does http://www.naturechina.com make?
• Monthly income for https://www.natureasia.com/ja-jp

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Particles.js
• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref